- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Kent Thiry on Creating Reimbursement Stability in Medicare Advantage
Medicare Advantage has the potential to be the most powerful part of the solution for American healthcare, but the government needs to create reimbursement stability in order for that to happen, said Kent Thiry, chief executive officer of DaVita Healthcare Partners Inc.
Medicare Advantage (MA) has the potential to be the most powerful part of the solution for American healthcare, but the government needs to create reimbursement stability in order for that to happen, Kent Thiry, chief executive officer of DaVita Healthcare Partners Inc, said at America’s Health Insurance Plans’ National Health Policy Conference in Washington, DC, March 11-12.
Studies have shown that when MA becomes a large part of providers’ business, they change how they do all business, which shows how the MA program can be a strategic asset for the country. However, it needs to be nurtured, he said.
“We need reimbursement stability and certainty in order to unleash the forces of innovation,” Mr Thiry said.
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
